Introduction
Plasma levels of high-density lipoprotein (HDL) cholesterol and its major apolipoprotein (apo), apo A-I, are inversely correlated with the incidence of ischemic cardiovascular diseases. 1 Evidence that HDL may inhibit progression of atherogenesis has been provided by investigations in human apo A-I transgenic mice and rabbits. [2] [3] [4] [5] Reverse cholesterol transport, that is, the centripetal cholesterol transport from peripheral cells to the liver for excretion into bile or to steroidogenic organs for steroid hormone synthesis, has been proposed to be the main mechanism underlying the atheroprotective effects of HDL. Increased HDL levels may reduce cholesterol accumulation in preexisting atherosclerotic lesions by stimulating reverse cholesterol transport. Previously, Badimon et al. 6 showed that treatment with 50 mg of HDL protein once a week for 4 weeks reduced aortic cholesterol content in preexisting lesions in New Zealand white rabbits fed a 0.5% cholesterol diet. In that study, 6 limited fatty streak lesions were induced during an induction period of 60 days and the intervention did not result in increased HDL cholesterol levels. Regression of early atherosclerotic lesions has also been demonstrated after human apo A-I gene transfer in lowdensity lipoprotein (LDL) receptor (LDLr)-deficient mice fed a proatherogenic diet. 7 Intervention in these LDLrdeficient mice was performed 5 weeks after the start of the diet and lasted for 4 weeks. Taken together, these prior studies did not investigate whether HDL may induce cholesterol unloading in advanced and complex atherosclerotic lesions and whether a long-term intervention may result in a sustained effect.
Lecithin:cholesterol acyltransferase (LCAT) catalyzes the transacylation of the fatty acid at the sn-2 position of phosphatidylcholine preferentially to the free 3-b-hydroxyl group of cholesterol in HDL and to a lesser extent in LDL particles. 8 Subsequent metabolism of these LCATgenerated cholesterol esters is highly species dependent. Unlike mice, rabbits have a lipoprotein metabolism that shows a significant degree of similarity with human lipoprotein metabolism. Rabbits do not edit apo B mRNA in the liver and produce only apo B-100-containing very low density lipoproteins as does human liver. 9 Furthermore, rabbits produce cholesterol ester transfer protein similar as humans. 10, 11 Consequently, HDL metabolism in rabbits is more similar to humans because cholesterol esters generated by LCAT on HDL may be transferred to apo B-containing lipoproteins with a reciprocal equimolar transfer of triglycerides in the reverse direction.
The goal of the current study was to evaluate the effect of increased HDL cholesterol induced by hepatocytedirected rabbit apo A-I or rabbit Lcat gene transfer on advanced and complex atherosclerotic lesions. Lesions were induced by feeding a 0.15% cholesterol diet for 420 days in heterozygous LDLr-deficient rabbits and the effect of gene transfer with E1E3E4-deleted adenoviral vectors was evaluated 120 days later. We demonstrate that increased HDL cholesterol following gene transfer inhibits progression of complex atherosclerotic lesions compared to a control progression group and that rabbit apo A-I and rabbit Lcat gene transfer reduce cholesterol content in the aorta compared to a baseline group killed after 420 days of diet. The current study shows for the first time that long-term gene therapeutic interventions that increase HDL cholesterol induce cholesterol unloading in complex atherosclerotic lesions.
Results
Effect of a 0.15% cholesterol diet on lipoproteins in LDLr +/À rabbits
To induce complex atherosclerotic lesions, heterozygous LDLr-deficient rabbits (n ¼ 45) were fed a 0.15% cholesterol-containing diet for 420 days starting from the age of 5 months. Non-HDL cholesterol and HDL cholesterol plasma levels during the atherosclerosis induction period are shown in Figures 1a and b , respectively, for the baseline group (n ¼ 14) killed after 420 days of cholesterol feeding, and for the adenoviral rabbit apo A-I (AdrA-I; n ¼ 10), the rabbit LCAT (AdrLCAT; n ¼ 11) and control vector (Adnull; n ¼ 10) gene transfer groups. As shown in Figures 1a and b , the average non-HDL cholesterol and HDL cholesterol levels were not significantly different in the four groups during the atherosclerosis induction period of 420 days. Compared to lipoprotein levels before start of the diet, non-HDL cholesterol increased approximately 5-fold in the different groups during the atherosclerosis induction period ( Figure 1a ). In contrast, compared to the HDL cholesterol plasma concentration before cholesterol feeding, HDL cholesterol levels progressively decreased during cholesterol feeding and were 2.1-fold (Po0.05), 1.7-fold (Po0.01), 1.7-fold (Po0.01) and 1.8-fold (Po0.01) lower after 420 days of cholesterol feeding in the baseline, AdrA-I, AdrLCAT and Adnull groups, respectively.
Gene transfer with AdrA-I or AdrLCAT selectively increases HDL cholesterol in LDLr +/À rabbits with diet-induced hyperlipidemia Gene transfer of 4 Â 10 12 particles per kg of E1E3E4-deleted adenoviral vectors was performed by intraportal administration preceded by intraportal injection of 0.3 mmol kg À1 of sodium decanoate at the age of 19 months after 420 days on a 0.15% cholesterol diet. Rabbits in the three gene transfer groups were maintained on a 0.15% cholesterol-containing diet for an additional 120 days until killing. Figures 2a and b show non-HDL cholesterol and HDL cholesterol plasma levels, respectively, after gene transfer with Adnull, AdrA-I and AdrLCAT. AdrA-I and AdrLCAT gene transfer persistently increased HDL cholesterol levels ( Figure 2 ). The average HDL cholesterol level increased 2.0-fold (Po0.001) and 1.9-fold (Po0.001) in the 120 days after transfer with AdrA-I and AdrLCAT, respectively, compared to levels just before transfer ( Figure 2 ). In contrast, the average HDL cholesterol level was not significantly altered after Adnull transfer and was 1.9-fold lower (Po0.001) compared to the AdrA-I and AdrLCAT groups ( Figure 2 ). Non-HDL cholesterol levels did not significantly change after gene transfer and were not different between the three groups.
Rabbit apo A-I levels determined by quantitative western blot and expressed as percentage of plasma levels before the start of the 0.15% cholesterol diet are shown in Table 1 . Consistent with the decrease of HDL cholesterol levels during the atherosclerosis induction period, rabbit apo A-I levels were significantly lower after 240 and 420 days of feeding. Determination of rabbit apo A-I at days 35 and 120 after gene transfer showed increased levels after AdrA-I and AdrLCAT but not after Adnull transfer compared to levels just before transfer (Table 1) .
Feeding a 0.15% cholesterol diet for 420 days induces complex atherosclerotic lesions in LDLr +/À rabbits Figure 3 shows representative images of complex fibroatheromatous lesions in the descending thoracic aorta of rabbits of the baseline group. Lesions were HDL-raising gene transfer inhibits progression of atherosclerosis in LDLr +/À rabbits fed a 0.15% cholesterol diet
The extent and histological composition of intimal lesions in the descending thoracic aorta in heterozygous LDLr +/À rabbits are shown in Table 2 for the four different groups. No significant differences of the intima/media ratio, macrophage, smooth muscle cell and collagen content were observed ( Table 2) . Nevertheless, there were clear trends for a lower intima/media ratio in the AdrA-I and AdrLCAT groups compared to the Adnull group. A post hoc analysis in which the AdrA-I and AdrLCAT rabbits were pooled in one group showed a 31% (Po0.05) reduction of the intima/media Figure 5 . Taken together, these data indicate that increased reverse cholesterol from complex atherosclerotic lesions after AdrA-I and AdrLCAT gene transfer results in a negative cholesterol balance in the lesions.
Discussion
The main findings of the current study are that (1) gene transfer with E1E3E4-deleted adenoviral vectors containing hepatocyte-specific expression cassettes to express rabbit apo A-I or rabbit LCAT induces a persistent selective elevation of HDL cholesterol in cholesterol-fed LDLr +/À rabbits; (2) increased HDL cholesterol following rabbit apo A-I or rabbit Lcat gene transfer inhibits progression of advanced atherosclerotic lesions and (3) both rabbit apo A-I and rabbit Lcat transfer induce cholesterol unloading in complex atherosclerotic lesions, consistent with enhanced reverse cholesterol transport from the vascular wall.
We have previously shown that the small diameter of sinusoidal fenestrae is a barrier for hepatocyte-directed transfer in New Zealand white rabbits. [14] [15] [16] Intraportal injection of sodium decanoate enlarges the diameter of fenestrae and potently increases transgene expression in New Zealand white rabbits.
14 Short-term pilot experiments with a human apo A-I expressing adenoviral vector in heterozygous LDLr-deficient rabbits showed that, similar as observed in New Zealand white rabbits, marginal ear vein injection resulted in very low human apo A-I levels whereas intraportal injection preceded by intraportal injection of sodium decanoate dramatically increased expression levels (data not shown). Therefore, this mode of gene transfer was applied in all gene transfer experiments in the current study.
To enable long-term expression of transgenes after transfer with E1E3E4-deleted vectors, autologous rabbit genes were used in the current study. In mice, use of hepatocyte-specific expression cassettes is associated with immunological ignorance or tolerance for human transgene products. [17] [18] [19] However, observations in rabbits are not in line with murine data. Previously, the development of neutralizing antibodies against human apo A-I resulted in undetectable human apo A-I levels within 14 days after human apo A-I transfer in New Zealand white rabbits.
14 In contrast, the absence of an adaptive immune response against human apo A-I after transfer in several murine strains contributed to sustained expression. 17, 18, [20] [21] [22] Obviously, prior studies in human apo A-I and human Lcat transgenic rabbits 3, 23 were not hampered by an immune response against human apo A-I or human LCAT, because tolerance for these transgene products develops during fetal life.
The aim of the current study was to investigate the effect of HDL-raising gene transfer on advanced complex atherosclerotic lesions. Rabbits were fed a low amount of cholesterol (0.15%) for a period of 420 days before Heterozygous LDLr +/À rabbits were fed a 0.15% cholesterol diet for 420 days (baseline; n ¼ 14) or a 0.15% cholesterol diet for 420 days followed by injection of AdrA-I (n ¼ 10), AdrLCAT (n ¼ 11) or Adnull (n ¼ 10) and an additional period of 120 days of feeding a 0.15% cholesterol diet. All data are expressed as means ± s.e.m. Differences between groups were not statistically significant by one-way analysis of variance. Table 2 .
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transfer. Feeding 0.15% cholesterol induced a pathophysiologically relevant degree of hypercholesterolemia and resulted in a decrease of HDL cholesterol. A decrease of HDL cholesterol following cholesterol feeding in rabbits has previously been observed [24] [25] [26] [27] but the mechanism has not been investigated. Compared to short-term feeding of high amounts of cholesterol, 28 feeding low percentages of dietary cholesterol for longer durations has been reported to produce more advanced lesions as well as complicated lesions containing cholesterol clefts and necrotic debris. [29] [30] [31] [32] [33] When different amounts of dietary cholesterol were compared, rabbits fed a 0.15% cholesterol diet showed the smallest individual variability in response to cholesterol feeding. 34 Reducing this variability enhances the statistical power of rabbit atherosclerosis studies that are inherently limited by the number of animals. Besides feeding lower amounts of cholesterol for a longer exposure time, an additional strategy to induce more complex lesions is cholesterol feeding in heterozygous LDLr-deficient rabbits. 35 Heterozygous LDLr-deficient rabbits fed a cholesterol diet have previously been shown to develop complicated lesions with necrotic cores, cholesterol clefts, fibrous caps and calcification. 35 These lesions in LDLr +/À rabbits were significantly more complex than in New Zealand white rabbits fed the same diet notwithstanding similar plasma cholesterol levels. 35 On the basis of these prior studies [29] [30] [31] [32] [33] [34] [35] we chose heterozygous LDLr-deficient rabbits fed a 0.15% cholesterol diet to induce complicated lesions. In our model, necrotic cores, cholesterol clefts, fibrous caps and calcification were indeed consistently observed (Figure 3 ).
There are several candidate genes to increase HDL cholesterol following gene transfer. In the current study, the effects of apo A-I and Lcat gene transfer were compared. Overexpression of apo A-I by transgenesis or gene transfer has shown to be an HDL cholesterol-raising strategy that consistently reduces progression of atherosclerosis independent of the genetic and metabolic context. [2] [3] [4] [5] 22 In contrast, overexpression of LCAT has been shown to inhibit progression of atherosclerosis in rabbits, 23, 36 whereas in mice progression of atherosclerosis was either enhanced 37 or no effect was observed. [38] [39] [40] Because this species difference in the effect 
of LCAT overexpression on atherosclerosis is likely due to the presence of cholesterol ester transfer protein in rabbits and the absence of cholesterol ester transfer protein in mice, we compared apo A-I and Lcat gene transfer in rabbits. Both transgenes resulted in a similar increase of HDL cholesterol and induced a similar degree of cholesterol unloading in advanced lesions in cholesterolfed heterozygous LDLr-deficient rabbits in the current study. No effect on non-HDL cholesterol was observed after AdrA-I or AdrLCAT gene transfer. In contrast, human apo A-I transgenic rabbits have been shown to be more sensitive to a diet-induced increase of HDL cholesterol. 3 In human Lcat transgenic rabbits, non-HDL cholesterol levels were lower secondary to an upregulation of the LDL receptor in the liver. 23, 36 The absence of effects on non-HDL cholesterol following rabbit apo A-I and rabbit Lcat gene transfer may be related to differences in genetic background, to the use of autologous genes or to the induction of a different metabolic program during fetal life in transgenic rabbits. The observation that both apo A-I and Lcat hepatocytedirected gene transfer have no effect on non-HDL cholesterol in the current study implies that the cholesterol unloading in the lesions may be attributed to enhanced reverse cholesterol transport from the vascular wall. Thus, increased HDL cholesterol levels following rabbit apo A-I and rabbit Lcat gene transfer were associated with an enhanced functionality of HDL. The absence of an effect on the macrophage content in the lesions is likely related to the low degree of inflammation in these fibroatheromatous lesions at baseline.
In conclusion, the current study demonstrates that rabbit apo A-I and rabbit Lcat gene transfer increase HDL cholesterol in cholesterol-fed heterozygous LDLr-deficient rabbits in the absence of an effect on non-HDL cholesterol levels. Raising HDL cholesterol inhibits progression of atherosclerosis and induces significant cholesterol unloading in complex fibroatheromatous lesions, consistent with enhanced reverse cholesterol transport from the vascular wall.
Materials and methods

Animal experiments
New Zealand white rabbits were obtained from the University of Gent (Merelbeke, Belgium). Watanabe heritable hyperlipidemic rabbits, 41, 42 characterized by homozygous LDLr deficiency, were originally obtained from Charles River Laboratories (Cléon, France). These rabbits with 100% Japanese white background were crossed with New Zealand white rabbits and the heterozygous female offspring was backcrossed with the homozygous males. The homozygous offspring was further backcrossed with 100% New Zealand white rabbits, until LDLr +/À rabbits in a final background of 62.5% New Zealand white and 37.5% Japanese white were generated. The LDLr genotype was determined as described before. 23, 43 To induce hypercholesterolemia in LDLr +/À rabbits, a diet containing 0.15% cholesterol at a daily food amount of 100 g was initiated at 5 months. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (publication no. 85-23, revised 1996).
Construction of an expression cassette for hepatocyte-specific overexpression of rabbit LCAT Total RNA was extracted from rabbit liver using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). A pool of rabbit RNA derived from multiple New Zealand white rabbits was treated with DNAse (Amersham Biosciences, Buckinghamshire, UK) and reverse transcribed with Superscript II RT (Invitrogen) at 42 1C for 50 min in the presence of 0.5 mM deoxynucleotide triphosphate (NTP), 0.01 M dithiotreitol (DTT), 1 Â first-strand buffer (Invitrogen) and 250 ng pd(N) 6 Construction of an expression cassette for hepatocyte-specific overexpression of rabbit apo A-I Genomic DNA was extracted from rabbit lung and the complete genomic rabbit apo A-I sequence 45 was amplified by PCR using the following primers: 5 0 -GCTCTAGAGCAGACTGCTTGGAGAGCTCCAGGA GGCGGG-3 0 and 5 0 -GCGTCGACGTGCTACTTTATTC TAAGACGCC-3 0 . By inclusion of an XbaI and an SalI site in the overhanging ends of the forward and reverse primers, respectively, rabbit apo A-I genomic sequence was subsequently cloned into the SalI/XbaI opened pLpA-hAAT.4xapoE, generating pLpA-hAAT.rapoA-I.4xapoE.
Vector production and gene transfer in heterozygous LDLr +/À rabbits Production of infectious plasmids and large-scale production of adenoviral vectors were performed as described previously.
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The E1E3E4-deleted control vector Adnull 46 does not contain an expression cassette whereas the E1E3E4-deleted vectors AdrA-I and AdrLCAT induce hepatocyte-specific expression of rabbit apo A-I and rabbit LCAT, respectively. To increase the diameter of sinusoidal fenestrae, intraportal injection of sodium decanoate (Sigma-Aldrich, Steinheim, Germany) at a dose of 0.3 mmol kg À1 was performed 10 min before intraportal gene transfer of 4 Â 10 12 adenoviral particles 
Blood sampling
Blood was obtained after an overnight fast from the central ear artery and anticoagulated with 1/10 volume of 4% trisodium citrate. Plasma was isolated by centrifugation at 1100 g for 10 min and stored at À20 1C.
Lipoprotein ultracentrifugation
Plasma lipoproteins were separated by density gradient ultracentrifugation in a swing-out rotor as described. 47 After centrifugation for 24 h at 40 000 r.p.m. using the SW41-Ti rotor for the LE-80 (Beckman Coulter, Palo Alto, CA, USA) ultracentrifuge, the VLDL fraction (do1.006 g ml
À1
) was collected from the top layer followed by IDL (1.006odo1.019 g ml À1 ), LDL (1.019 odo1.063 g ml
) and HDL (d41.063 g ml
). VLDL, IDL and LDL together constitute non-HDL particles.
Plasma lipid analysis
Biochemical determination of cholesterol and triglycerides was performed as described before. 48 Quantification of rabbit apo A-I by western blot Five microliters of plasma, 8.3 ml of loading buffer and 36.7 ml H 2 O were mixed and heated to 100 1C for 10 min. Ten microliters of this mix was separated on a 12% SDS-polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane (Amersham Biosciences) by semidry blotting (LKB electroblot apparatus; LKB, Bromma, Sweden) in transfer buffer (25 mM Tris, 190 mM glycine, 20% (v/v) methanol, 0.1% SDS, pH 7.5) for 75 min. The membrane was probed overnight with a goat polyclonal antibody against human apo A-I cross-reacting with rabbit apo A-I in a dilution of 1:5000 (Rockland Inc., Gilbertsville, PA, USA). Horseradishperoxidase-conjugated rabbit anti-goat antibodies (Dako, Glostrup, Denmark) were applied in a dilution of 1:1000 for 1 h and then developed using ECL detection reagent (Amersham Biosciences). Films were scanned together with a set of calibration slides with known OD values. Protein levels were quantified by digital measurement of mean gray values using KS300 imaging software (Zeiss, Zaventem, Belgium). Rabbit apo A-I protein levels are expressed as relative units compared to the expression level at baseline.
Histological analysis
At the age of 19 months (baseline group) or 23 months (AdrA-I, AdrLCAT and Adnull groups), rabbits were anesthetized with 12.5 mg kg À1 Ketamine 1000 Ceva (Ceva Animal Care, Brussels, Belgium) and 5 mg kg À1 Rompun (Bayer, Gent, Belgium) subcutaneously and killed by intravenous injection of an overdose sodium pentobarbital together with heparin (100 mg kg À1 , intravenous) to prevent post-mortem clotting. The descending thoracic aorta was excised, immersed in Dulbecco's modified Eagle's medium (Gibco, Carlsbad, CA, USA) and adventitial fat was removed. Two adjacent segments were excised. The proximal segments were embedded in OCT compound and snap-frozen in liquid nitrogen. Caudal segments were immersion fixed in 1% paraformaldehyde overnight followed by paraffin embedding. Paraffin-embedded sections (7 mm thick) were stained with hematoxylin and eosin for quantification of the intimal, medial and luminal areas at 170-mmspaced intervals. To determine the relative collagen content in the intima, paraffin sections stained with sirius red (Sigma-Aldrich) were observed under polarized light 49 and the thick, tightly packed red-colored collagen fibers were quantified as percentage of the intimal area. Relative lipid content within the lesions was determined by staining cryosections with Oil Red O (BDH Laboratory Supplies, Poole, UK). For all stainings, computer-assisted image analysis was performed in a blinded manner using KS300 software (Zeiss). For all parameters determined, at least five sections per rabbit were analyzed.
Immunohistochemistry
Paraffin-embedded sections were stained immunohistochemically with monoclonal mouse antibodies against RAM11 (1:50 dilution; Dako) for macrophages and against human smooth muscle a-actin antibodies (1:500 dilution; Dako) for vascular smooth muscle cells. The relative macrophage or smooth muscle cell content as percentage of intimal area within the red color range of the spectrum was determined by computer-assisted image analysis using KS300 software (Zeiss).
Statistical analysis
All data are expressed as means±standard error of the means (s.e.m.). Areas under the curve were calculated using Prism4 (GraphPad Software, San Diego, CA, USA). Lipid and histological parameters between different groups were compared by analysis of variance followed by Tukey's multiple comparison post-test (GraphPad Software). A two-sided P-value of less than 0.05 was considered statistically significant.
Abbreviations
Apo, apolipoprotein; LCAT, lecithin:cholesterol acyltransferase; LDL, low-density lipoproteins; HDL, highdensity lipoproteins; LDLr, low-density lipoprotein receptor.
